Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
Contraception Journal
Send To A Friend Send To A Friend Bookmark this Page Share this page
Contraception Highlights September 2016

Editorial

WHO medical eligibility criteria update
Mary Lyn Gaffield, James Kiarie
Login to read full article

Reviews

Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use
Monica V. Dragoman, Tara Jatlaoui, Kavita Nanda, Kathryn M. Curtis, Mary E. Gaffield
Read full article

The safety of subcutaneously administered depot medroxyprogesterone acetate (104 mg/0.65 mL): A systematic review
Monica V. Dragoman, Mary E. Gaffield
Read full article

The safety of Sino-implant (II) for women with medical conditions or other characteristics: a systematic review
Sharon J. Phillips, Petrus S. Steyn, Kathryn M. Curtis
Read full article

Progestogen-only contraceptive use among breastfeeding women: a systematic review
Sharon J. Phillips, Naomi K. Tepper, Nathalie Kapp, Kavita Nanda, Marleen Temmerman, Kathryn M. Curtis
Read full article

Safety of the progesterone-releasing vaginal ring (PVR) among lactating women: A systematic review
Shannon L. Carr, Mary E. Gaffield, Monica V. Dragoman, Sharon Phillips
Read full article

Combined hormonal contraceptive use among breastfeeding women: an updated systematic review
Naomi K. Tepper, Sharon J. Phillips, Nathalie Kapp, Mary E. Gaffield, Kathryn M. Curtis
Read full article

Superficial venous disease and combined hormonal contraceptives: a systematic review
Naomi K. Tepper, Polly A. Marchbanks, Kathryn M. Curtis
Read full article

Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes
Monica Dragoman, Kathryn M. Curtis, Mary E. Gaffield
Read full article

Corrigendum

Corrigendum to “Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A” [Contraception 2016;93:498–506]
Patrick Rowe, Tim Farley, Alexandre Peregoudov, Gilda Piaggio, Simone Boccard, Sihem Landoulsi, Olav Meirik, for the IUD Research Group of the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction
Read full article